- Home
- FND vs CORT Comparison
FND vs CORT Comparison
Compare FND & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FND | CORT |
|---|---|---|
| Founded | 2000 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 8.6B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | FND | CORT |
|---|---|---|
| Price | $64.75 | $37.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 6 |
| Target Price | $82.59 | ★ $111.00 |
| AVG Volume (30 Days) | 2.3M | ★ 2.7M |
| Earning Date | 02-19-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.08 | N/A |
| EPS | ★ 2.00 | 0.87 |
| Revenue | ★ $4,661,833,000.00 | $741,172,000.00 |
| Revenue This Year | $6.22 | $23.96 |
| Revenue Next Year | $7.82 | $43.40 |
| P/E Ratio | ★ $32.89 | $40.96 |
| Revenue Growth | 6.04 | ★ 17.92 |
| 52 Week Low | $55.11 | $32.99 |
| 52 Week High | $108.76 | $117.33 |
Technical Indicators
Market Signals| Indicator | FND | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 56.12 | 20.03 |
| Support Level | $60.38 | $34.28 |
| Resistance Level | $63.82 | $85.34 |
| Average True Range (ATR) | 2.06 | 3.71 |
| MACD | 0.42 | -5.58 |
| Stochastic Oscillator | 59.00 | 7.98 |
Price Performance
Historical ComparisonAbout FND Floor & Decor Holdings Inc.
Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.